(Q53604684)

16 May 2018

title

Adjuvant effects of adenylate cyclase toxin of Bordetella pertussis after intranasal immunisation of mice. (English)

1 reference

16 May 2018

1 reference

Barbara Orr

1

1 reference

16 May 2018

Gillian Douce

2

1 reference

16 May 2018

Susan Baillie

3

1 reference

16 May 2018

Roger Parton

4

1 reference

16 May 2018

John Coote

5

1 reference

16 May 2018

language of work or name

English

0 references

publication date

31 July 2006

1 reference

16 May 2018

number of pages

8

1 reference

inferred from page(s)

published in

Vaccine

1 reference

16 May 2018

volume

25

1 reference

16 May 2018

issue

1

1 reference

16 May 2018

page(s)

64-71

1 reference

16 May 2018

Acellular pertussis vaccines

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.07.019

Immunity to Bordetella pertussis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.07.019

Protection of mice against respiratory Bordetella pertussis infection by intranasal immunization with P.69 and FHA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.07.019

Mucosal and systemic immunogenicity of a recombinant, non-ADP-ribosylating pertussis toxin: effects of formaldehyde treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.07.019

Immune responses and protection against Bordetella pertussis infection after intranasal immunization of mice with filamentous haemagglutinin in solution or incorporated in biodegradable microparticles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.07.019

Mucosal and systemic antibody responses against an acellular pertussis vaccine in mice after intranasal co-administration with recombinant cholera toxin B subunit as an adjuvant

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.07.019

Mucosal vaccines: non toxic derivatives of LT and CT as mucosal adjuvants.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.07.019

The adenylate cyclase toxin of Bordetella pertussis binds to target cells via the alpha(M)beta(2) integrin (CD11b/CD18)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.07.019

Neutralizing antibodies to adenylate cyclase toxin promote phagocytosis of Bordetella pertussis by human neutrophils

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.07.019

Human serologic response to envelope-associated proteins and adenylate cyclase toxin of Bordetella pertussis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.07.019

Antibodies to Bordetella pertussis adenylate cyclase are produced in man during pertussis infection and after vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.07.019

Determination of serum antibody to Bordetella pertussis adenylate cyclase toxin in vaccinated and unvaccinated children and in children and adults with pertussis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.07.019

Protective activity of Bordetella adenylate cyclase-hemolysin against bacterial colonization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.07.019

Adjuvant and protective properties of native and recombinant Bordetella pertussis adenylate cyclase toxin preparations in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.07.019

Adenylate cyclase toxin from Bordetella pertussis synergizes with lipopolysaccharide to promote innate interleukin-10 production and enhances the induction of Th2 and regulatory T cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.07.019

Adjuvanticity of native and detoxified adenylate cyclase toxin of Bordetella pertussis towards co-administered antigens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.07.019

Bordetella pertussis adenylate cyclase toxin: proCyaA and CyaC proteins synthesised separately in Escherichia coli produce active toxin in vitro.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.07.019

Mucosal adjuvanticity and immunogenicity of LTR72, a novel mutant of Escherichia coli heat-labile enterotoxin with partial knockout of ADP-ribosyltransferase activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.07.019

From toxin to adjuvant: the rational design of a vaccine adjuvant vector, CTA1-DD/ISCOM.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.07.019

Bordetella pertussis adenylate cyclase toxin modulates innate and adaptive immune responses: distinct roles for acylation and enzymatic activity in immunomodulation and cell death.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.07.019

The adenylate cyclase of Bordetella pertussis: a vector to target antigen presenting cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.07.019

Enzyme-linked immunosorbent assay for detection of pertussis immunoglobulin A in nasopharyngeal secretions as an indicator of recent infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.07.019

7 January 2021

Characterization of antibody inhibiting adherence of Bordetella pertussis to human respiratory epithelial cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.07.019

7 January 2021

Mucosal immunization with filamentous hemagglutinin protects against Bordetella pertussis respiratory infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.07.019

7 January 2021

Role of adenylate cyclase-hemolysin in alveolar macrophage apoptosis during Bordetella pertussis infection in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.07.019

7 January 2021

CyaC-mediated activation is important not only for toxic but also for protective activities of Bordetella pertussis adenylate cyclase-hemolysin.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.07.019

7 January 2021

10.1016/J.VACCINE.2006.07.019

Identifiers

DOI

1 reference

16 May 2018

1 reference

16 May 2018